{"id":10721,"date":"2022-05-31T09:18:16","date_gmt":"2022-05-31T07:18:16","guid":{"rendered":"https:\/\/ggba.swiss\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/"},"modified":"2023-07-04T13:43:57","modified_gmt":"2023-07-04T11:43:57","slug":"retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/","title":{"rendered":"RetinAI signe un accord de licence pluriannuel avec Novartis"},"content":{"rendered":"\n<p>Reposant sur l&rsquo;apprentissage automatique et la vision par ordinateur, la plateforme Discovery UNITY de la soci\u00e9t\u00e9 bernoise <a href=\"https:\/\/www.retinai.com\/\" target=\"_blank\" rel=\"noopener\">RetinAI<\/a> permet aux organisations internationales de regrouper les donn\u00e9es d&rsquo;imagerie afin d&rsquo;am\u00e9liorer la compr\u00e9hension des populations de patients et des r\u00e9sultats \u00e0 grande \u00e9chelle.<\/p>\n<p>Les capacit\u00e9s d&rsquo;IA int\u00e9gr\u00e9es \u00e0 la plateforme acc\u00e9l\u00e8rent le traitement des donn\u00e9es avec une analyse et l&rsquo;extraction d&rsquo; insights \u00e0 un haut niveau d&rsquo;expertise. Les utilisateurs peuvent ainsi appliquer les outils les plus avanc\u00e9s de RetinAI pour soutenir leur pipeline de recherche et de d\u00e9veloppement clinique en ophtalmologie, en acc\u00e9l\u00e9rant l&rsquo;analyse des donn\u00e9es et les flux de recherche.<\/p>\n<p>Des entreprises comme <a href=\"https:\/\/www.novartis.com\/\" target=\"_blank\" rel=\"noopener\">Novartis<\/a> peuvent utiliser la plateforme RetinAI pour caract\u00e9riser les maladies et les r\u00e9sultats des patients en se basant sur un syst\u00e8me de collecte et une organisation de donn\u00e9es \u00e0 grande \u00e9chelle reposant sur l&rsquo;application d&rsquo;une IA bas\u00e9e sur des mod\u00e8les de recherche sur les maladies ophtalmologiques approuv\u00e9s par la r\u00e9glementation. Les mod\u00e8les d&rsquo;IA de la plateforme comprennent des applications pour la d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l&rsquo;\u00e2ge (y compris l&rsquo;atrophie g\u00e9ographique), la r\u00e9tinopathie diab\u00e9tique, l&rsquo;\u0153d\u00e8me maculaire diab\u00e9tique, l&rsquo;occlusion veineuse r\u00e9tinienne et le glaucome.<\/p>\n<p>\u00ab\u00a0Nous sommes tr\u00e8s enthousiastes \u00e0 l&rsquo;id\u00e9e de poursuivre notre relation existante avec Novartis et nous les consid\u00e9rons comme un partenaire important dans la mise en \u0153uvre de l&rsquo;avenir de la m\u00e9decine de pr\u00e9cision num\u00e9rique. Nous pensons que la plateforme UNITY de RetinAI va red\u00e9finir la fa\u00e7on dont l&rsquo;analyse des donn\u00e9es est effectu\u00e9e dans le d\u00e9veloppement des m\u00e9dicaments, en cr\u00e9ant des opportunit\u00e9s pour une recherche plus rentable et plus cibl\u00e9e en mati\u00e8re de d\u00e9couverte et de planification des essais cliniques\u00a0\u00bb, a d\u00e9clar\u00e9 Carlos Ciller, CEO de RetinAI.<\/p>\n<p>La plateforme b\u00e9n\u00e9ficie du marquage CE et a re\u00e7u la validation de la Food and Drugs Administration am\u00e9ricaine.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La soci\u00e9t\u00e9 bernoise RetinAI et le g\u00e9ant pharmaceutique Novartis ont conclu une collaboration \u00e0 long terme avec un accord de licence pluriannuel pour le logiciel Discovery UNITY.<\/p>\n","protected":false},"author":3,"featured_media":10722,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1016,1033,1069],"class_list":["post-10721","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-artificial-intelligence-fr","tag-digital-health-fr","tag-pharma-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RetinAI signe un accord de licence pluriannuel avec Novartis - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RetinAI signe un accord de licence pluriannuel avec Novartis - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"La soci\u00e9t\u00e9 bernoise RetinAI et le g\u00e9ant pharmaceutique Novartis ont conclu une collaboration \u00e0 long terme avec un accord de licence pluriannuel pour le logiciel Discovery UNITY.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-31T07:18:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:43:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/RetinAI-Novartis-630x380-1-2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"RetinAI signe un accord de licence pluriannuel avec Novartis\",\"datePublished\":\"2022-05-31T07:18:16+00:00\",\"dateModified\":\"2023-07-04T11:43:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/\"},\"wordCount\":365,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/RetinAI-Novartis-630x380-1-2.jpeg\",\"keywords\":[\"Artificial Intelligence\",\"Digital Health\",\"Pharma\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/\",\"name\":\"RetinAI signe un accord de licence pluriannuel avec Novartis - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/RetinAI-Novartis-630x380-1-2.jpeg\",\"datePublished\":\"2022-05-31T07:18:16+00:00\",\"dateModified\":\"2023-07-04T11:43:57+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/RetinAI-Novartis-630x380-1-2.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/RetinAI-Novartis-630x380-1-2.jpeg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RetinAI signe un accord de licence pluriannuel avec Novartis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RetinAI signe un accord de licence pluriannuel avec Novartis - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/","og_locale":"fr_FR","og_type":"article","og_title":"RetinAI signe un accord de licence pluriannuel avec Novartis - Greater Geneva Bern area","og_description":"La soci\u00e9t\u00e9 bernoise RetinAI et le g\u00e9ant pharmaceutique Novartis ont conclu une collaboration \u00e0 long terme avec un accord de licence pluriannuel pour le logiciel Discovery UNITY.","og_url":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2022-05-31T07:18:16+00:00","article_modified_time":"2023-07-04T11:43:57+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/RetinAI-Novartis-630x380-1-2.jpeg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"RetinAI signe un accord de licence pluriannuel avec Novartis","datePublished":"2022-05-31T07:18:16+00:00","dateModified":"2023-07-04T11:43:57+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/"},"wordCount":365,"image":{"@id":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/RetinAI-Novartis-630x380-1-2.jpeg","keywords":["Artificial Intelligence","Digital Health","Pharma"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/","url":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/","name":"RetinAI signe un accord de licence pluriannuel avec Novartis - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/RetinAI-Novartis-630x380-1-2.jpeg","datePublished":"2022-05-31T07:18:16+00:00","dateModified":"2023-07-04T11:43:57+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/RetinAI-Novartis-630x380-1-2.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/RetinAI-Novartis-630x380-1-2.jpeg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/retinai-signe-un-accord-de-licence-pluriannuel-avec-novartis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"RetinAI signe un accord de licence pluriannuel avec Novartis"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/10721","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=10721"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/10721\/revisions"}],"predecessor-version":[{"id":18164,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/10721\/revisions\/18164"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/10722"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=10721"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=10721"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=10721"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}